BRYAN ESPINET: Open Payments
NPI 1285310599 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$726 in 46 payments from 10 companies in 2025. Trend: 2023 $285 · 2024 $741 · 2025 $726
Food & beverage: $726
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $227 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $198 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Almatica Pharma LLC | 4 | $61 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Teva Pharmaceuticals USA, Inc. | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $14 |
Products named: VRAYLAR, CAPLYTA, REXULTI, LOREEV XR, SPRAVATO, Auvelity, AUSTEDO XR, TRINTELLIX.
Industry payments across FL — which companies pay providers there.
